PLAS-FREE

Innovative Blood Filtration Technology

Health Tech & Life Sciences
Active
Series A Nazareth, Israel Founded 2017
Last updated 2026-06-18
Total raised
$9.2M
Last: 2024-03
Stage
Series A
Founded
2017
Headcount
20
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences

About

Plas-Free is an Israel-based company specializing in the development of blood filtration systems. Its main product, ClearPlasma, is a single-use device designed to extract plasminogen, a key protein responsible for dissolving blood clots. By removing plasminogen from plasma units designated for transfusion, ClearPlasma enhances coagulation and promotes hemostasis. This technology has been proven in multiple clinical trials conducted in Israel and Europe. In addition, Plas-Free is developing the Ammonia Adsorption Column-300 (AAPC-300), designed to reduce toxic accumulation in patients with liver failure. This technology is currently in pre-clinical trials. Plas-Free’s unique medical devices contribute to the Israeli medical ecosystem by integrating bio-convergence, combining chemistry, biology, and engineering to advance innovative healthcare solutions.

Funding history · 6 rounds · $9.2M total

2024-03
$4.8M
2022-02
$2.0M
2021-12
2020-01
$1.6M
2019-10
Grant Undisclosed
2017-08
$850K

Q&A

What is PLAS-FREE's primary product?
PLAS-FREE's main product is ClearPlasma, a single-use device designed to extract plasminogen from plasma units for transfusion, which enhances coagulation and promotes hemostasis.
What other technology is PLAS-FREE developing?
PLAS-FREE is developing the Ammonia Adsorption Column-300 (AAPC-300), which aims to reduce toxic accumulation in patients with liver failure. This technology is currently in pre-clinical trials.
When was PLAS-FREE founded?
PLAS-FREE was founded in August 2017.
What is PLAS-FREE's employee count?
PLAS-FREE has an employee count in the 11-50 range.
What is the total amount of funding PLAS-FREE has raised to date?
PLAS-FREE has raised a total of $9,217,000 USD.
When was PLAS-FREE's most recent funding round?
PLAS-FREE's most recent funding round occurred in March 2024, raising $4,750,000 USD.
Which investor participated in PLAS-FREE's initial funding round in August 2017?
NGT3 participated in PLAS-FREE's funding round in August 2017.
What is PLAS-FREE's current funding stage?
PLAS-FREE is currently in its Series A funding stage.
Who are the founders of PLAS-FREE?
The founders of PLAS-FREE are Zeev Dvashi, who serves as Founder & CEO, and Abed Elrauf Hijazi, who is Co-Founder & CMO.

Team · 2

Founder · Founder & CEO
LinkedIn ↗
Founder · Co-Founder & CMO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-deviceshospitalshealthcare-providerstreatmentsblood-test
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteplas-free.com/
LinkedInlinkedin.com/company/27098247

Identifiers & details

Founded2017-8
Employees (exact)20

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainplas-free.com

Certificate / subdomain footprint

Subdomains2